Visual function and retinal changes in patients with optic neuritis. / Dale, Gro Helen; Petersen, Thor; Christensen, Tove; Svendsen, Kristina Bacher; Bek, Toke.
2015. Poster session præsenteret ved Dansk Neurologisk Selskabs Årsmøde, Vejle, Danmark.Publikation: Konferencebidrag › Poster › Forskning
Biomarkers for treatment efficacy and prognosis in multiple sclerosis. / Stilund, Morten Leif; Christensen, Tove; Møller, Holger Jon; Rasmussen, Peter Vestergaard; Petersen, Thor.
2014. Abstract fra Aarhus University Graduate School of Health, PhD Day 2014, Aarhus, Danmark.Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning
Direct Pathogenic Effects of HERV-encoded Proteins. / Hansen, Dorte Tranberg; Møller-Larsen, Anné; Petersen, Thor; Petersen, Eva Lykke; Christensen, Tove.
2014. Poster session præsenteret ved Aarhus University Graduate School of Health, PhD Day 2014, Aarhus, Danmark.Publikation: Konferencebidrag › Poster › Forskning
Can early treatment with Solu-medrol prevent visual loss after optic neuritis? / Dale, Gro Helen; Bek, Toke; Christensen, Tove; Svendsen, Kristina Bacher; Petersen, Thor.
2014. Poster session præsenteret ved Aarhus University Graduate School of Health, PhD Day 2014, Aarhus, Danmark.Publikation: Konferencebidrag › Poster › Forskning
Diagnostic contribution of soluble CD163 to a panel of biomarkers in newly diagnosed patients with multiple sclerosis. / Stilund, Morten Leif; Gjelstrup, Mikkel Carstensen; Petersen, Thor; Møller, Holger Jon; Rasmussen, Peter Vestergaard; Christensen, Tove.
I: Multiple Sclerosis, Bind 20 SI, 2014, s. 179.Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Konferenceabstrakt i tidsskrift › Forskning › peer review
Possible prognostic factors for visual function after optic neuritis. / Dale, Gro Helen; Svendsen, Kristina Bacher; Petersen, Thor; Christensen, Tove; Bek, Toke.
2014.Publikation: Konferencebidrag › Poster › Forskning
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis. / Stilund, Morten Leif; Reuschlein, Ann-Kathrin; Christensen, Tove; Møller, Holger Jon; Rasmussen, Peter Vestergaard; Petersen, Thor.
I: P L o S One, Bind 9, Nr. 6, 2014, s. e98588.Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review
Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells. / Møller-Larsen, A; Brudek, T; Petersen, T; Petersen, E L; Aagaard, M; Hansen, Dorte; Christensen, T.
I: Clinical and Experimental Immunology, Bind 173, Nr. 3, 09.2013, s. 398-410.Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review
HERVs: have we been here before? / Christensen, Tove; Giovannoni, Gavin.
I: Multiple Sclerosis Journal, Bind 19, 2013, s. 827-829.Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Leder › Forskning › peer review
Soluble CD163 as a diagnostic marker in multiple sclerosis. / Stilund, Morten Leif; Møller, Holger Jon; Reuschlein, AK; Christensen, Tove; Rasmussen, Peter Vestergaard; Petersen, Thor.
2013. Poster session præsenteret ved Aarhus University Graduate School of Health, PhD Day 2013, Aarhus, Danmark.Publikation: Konferencebidrag › Poster › Forskning › peer review